Changwei Lu
First Affiliated Hospital of GuangXi Medical University(CN)Hechi University(CN)
Publications by Year
Research Areas
MicroRNA in disease regulation, Bone Metabolism and Diseases, Bone health and osteoporosis research, Spine and Intervertebral Disc Pathology, Extracellular vesicles in disease
Most-Cited Works
- → Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation(2016)582 cited
- → Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference–based bone anabolic strategy(2015)343 cited
- → Osteoclastic miR-214 targets TRAF3 to contribute to osteolytic bone metastasis of breast cancer(2017)84 cited
- → Increased PLEKHO1 within osteoblasts suppresses Smad-dependent BMP signaling to inhibit bone formation during aging(2017)42 cited
- → Targeting osteoblastic casein kinase-2 interacting protein-1 to enhance Smad-dependent BMP signaling and reverse bone formation reduction in glucocorticoid-induced osteoporosis(2017)28 cited
- → Effects of teriparatide compared with risedronate in the treatment of osteoporosis(2020)8 cited
- → Author Correction: Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation(2025)1 cited
- → POEMS syndrome with cardiovascular lesions as the initial manifestation: a case report and literature review(2026)
- → Refining the assessment of robotic-assisted spine surgery: critical considerations for disease complexity, osteoporosis, and segment count(2025)
- → Letter to the Editor Regarding “Increased Risk of Lumbar Fusion Following Sacroiliac Joint Fusion in Patients With Lumbar Degenerative Disease: A Nationwide Cohort Analysis”(2025)